Denator AB. (5/31/11). "Press Release: Denator Appoints New Member to the Board". Gothenburg.

	Region	Göteborg (Gothenburg)
	Country	Sweden
	Organisation	Denator AB
	Product	sample preparation (technology)
	Product 2	pharmaceutical
	Person	Nicklasson, Martin (Biovitrum 200505– CEO before AstraZeneca AB CEO before Astra before Kabi Pharmacia)
	Person 2	Sköld, Olof (Denator AB 201106 CEO)

Denator AB announced today that Dr. Martin Nicklasson has been appointed as a new Board Member with immediate effect.

Dr Nicklasson has over 30 years' experience in the pharmaceutical industry, holding senior executive management positions over the past 20 years such as CEO at Astra Zeneca AB, Chairman of the board at Astra Tech and CEO at Biovitrum AB. Most recently, he served as President and CEO for Swedish Orphan Biovitrum AB (SOBI). Dr Nicklasson is currently a board member of, amongst others, the Swedish Heart & Lung Foundation, Scandinavian Life Science Invest AB and Biocrine AB.

Olof Sköld, CEO at Denator stated, "We are delighted to welcome Dr. Nicklasson to our Board. His extensive knowledge, experience and proven expertise in the pharmaceutical industry, one of our most important market segments, will be a very valuable addition to our company."

Record changed: 2011-11-27

Follow Us!

Top News

Upcoming Events

Associations

Partners

Denator AB. (5/31/11). "Press Release: Denator Appoints New Member to the Board". Gothenburg.

More documents for Denator AB